CD274 and neoplasm: The importance of CD226 in regulating anti-tumor responses is demonstrated in mouse tumor models where use of a CD226-neutralizing monoclonal antibody (mAb) abrogates the efficacy of combining mAbs against PD-L1 and TIGIT (Johnston et al., 2014).